# Daptomycin in Sodium Chloride

NDC: 0338-0718
Generic name: Daptomycin in Sodium Chloride
Labeler / Manufacturer: Baxter Healthcare Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20220125

FDA application: NDA213645

## Active ingredients

- DAPTOMYCIN: 1000 mg/100mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0338-0718"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0338-0718
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7ed4d986-2aa9-43cd-9a8a-fbd11cb5ecef